134 related articles for article (PubMed ID: 27241922)
21. [Surgery alone or in association with preoperative uterovaginal brachytherapy for stage IB1 cervical cancer: Toxicities profiles].
Lamblin G; Rouffiac M; Mathevet P; Martin E; Peignaux-Casasnovas K; Chabert P; Lebail-Carval K; Chene G
Gynecol Obstet Fertil; 2015; 43(7-8):485-90. PubMed ID: 25986397
[TBL] [Abstract][Full Text] [Related]
22. Propensity Score Analysis of Radical Hysterectomy Versus Definitive Chemoradiation for FIGO Stage IIB Cervical Cancer.
Tomita N; Mizuno M; Makita C; Kondo S; Mori M; Sakata J; Tsubouchi H; Hirata K; Tachibana H; Kodaira T
Int J Gynecol Cancer; 2018 Oct; 28(8):1576-1583. PubMed ID: 30095702
[TBL] [Abstract][Full Text] [Related]
23. Pattern of failures and clinical outcome of patients with locally advanced cervical cancer treated with a tailored integrated therapeutic approach.
Gadducci A; Fabrini MG; Perrone F; Manfredi B; Fanucchi A; Laliscia C; Barsotti C; Scotti V; Genazzani AR; Greco C
Anticancer Res; 2010 Sep; 30(9):3731-5. PubMed ID: 20944162
[TBL] [Abstract][Full Text] [Related]
24. Perioperative morbidity and rate of upstaging after laparoscopic staging for patients with locally advanced cervical cancer: results of a prospective randomized trial.
Köhler C; Mustea A; Marnitz S; Schneider A; Chiantera V; Ulrich U; Scharf JP; Martus P; Vieira MA; Tsunoda A
Am J Obstet Gynecol; 2015 Oct; 213(4):503.e1-7. PubMed ID: 25986030
[TBL] [Abstract][Full Text] [Related]
25. Patterns of failure after use of (18)F-FDG PET/CT in integration of extended-field chemo-IMRT and 3D-brachytherapy plannings for advanced cervical cancers with extensive lymph node metastases.
Chung YL; Horng CF; Lee PI; Chen FL
BMC Cancer; 2016 Mar; 16():179. PubMed ID: 26940959
[TBL] [Abstract][Full Text] [Related]
26. [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].
Hu JL; Wu LY; Li N; Li XG; Huang MN; Zhang R
Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):452-7. PubMed ID: 22932113
[TBL] [Abstract][Full Text] [Related]
27. [Laparoscopic radical hysterectomy after initial brachytherapy for stage IB1 cervical cancer: feasibility and results].
Uzan C; Nikpayam M; Merlot B; Gouy S; Belghiti J; Haie-Meder C; Nickers P; Narducci F; Morice P; Leblanc E
Gynecol Obstet Fertil; 2013 Oct; 41(10):571-7. PubMed ID: 24139815
[TBL] [Abstract][Full Text] [Related]
28. Chemoradiation with paclitaxel and carboplatin in high-risk cervical cancer patients after radical hysterectomy: a Korean Gynecologic Oncology Group study.
Lee TS; Kang SB; Kim YT; Park BJ; Kim YM; Lee JM; Kim SM; Kim YT; Kim JH; Kim KT
Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):304-10. PubMed ID: 23642625
[TBL] [Abstract][Full Text] [Related]
29. Patterns of spread in node-positive cervical cancer: the relationship between local control and distant metastases.
Stock RG; Chen AS; Karasek K
Cancer J Sci Am; 1996; 2(5):256-62. PubMed ID: 9166542
[TBL] [Abstract][Full Text] [Related]
30. Impact of preoperative brachytherapy followed by radical hysterectomy in stage IB2 (FIGO 2018) cervical cancer: An analysis of SENTICOL I-II trials.
Kissel M; Balaya V; Guani B; Magaud L; Mathevet P; Lécuru F;
Gynecol Oncol; 2023 Mar; 170():309-316. PubMed ID: 36758421
[TBL] [Abstract][Full Text] [Related]
31. Treatment patterns of FIGO Stage IB2 cervical cancer: a single-institution experience of radical hysterectomy with individualized postoperative therapy and definitive radiation therapy.
Zivanovic O; Alektiar KM; Sonoda Y; Zhou Q; Iasonos A; Tew WP; Diaz JP; Chi DS; Barakat RR; Abu-Rustum NR
Gynecol Oncol; 2008 Nov; 111(2):265-70. PubMed ID: 18774596
[TBL] [Abstract][Full Text] [Related]
32. Pre-hysterectomy cone biopsy is able to predict response in locally advanced cervical cancer patients submitted to neo-adjuvant chemoradiation.
Fanfani F; Fagotti A; Gagliardi ML; Ferrandina G; Monterossi G; Gallotta V; Zannoni GF; Scambia G
Eur J Surg Oncol; 2013 Sep; 39(9):1025-9. PubMed ID: 23827381
[TBL] [Abstract][Full Text] [Related]
33. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016
[TBL] [Abstract][Full Text] [Related]
34. Sexual function after modified radical hysterectomy (Piver II/Type B) vs. classic radical hysterectomy (Piver III/Type C2) for early stage cervical cancer. A prospective study.
Plotti F; Nelaj E; Sansone M; Antonelli E; Altavilla T; Angioli R; Benedetti Panici P
J Sex Med; 2012 Mar; 9(3):909-17. PubMed ID: 22372655
[TBL] [Abstract][Full Text] [Related]
35. Combined external and intracavitary irradiation in treatment of advanced cervical carcinomas: predictive factors for local tumor control and early recurrences.
Sorbe B; Bohr L; Karlsson L; Bermark B
Int J Oncol; 2010 Feb; 36(2):371-8. PubMed ID: 20043071
[TBL] [Abstract][Full Text] [Related]
36. Definitive chemoradiotherapy for advanced cervical cancer: should it be different in the elderly?
Caires IQ; Souza KT; Negrão MV; de Oliveira JA; Barroso-Sousa R; de Lima RC; Hoff PM; Diz Mdel P
Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():86-9. PubMed ID: 26182837
[TBL] [Abstract][Full Text] [Related]
37. Clinical outcomes of definitive chemoradiation followed by intracavitary pulsed-dose rate image-guided adaptive brachytherapy in locally advanced cervical cancer.
Castelnau-Marchand P; Chargari C; Maroun P; Dumas I; Del Campo ER; Cao K; Petit C; Martinetti F; Tafo-Guemnie A; Lefkopoulos D; Morice P; Haie-Meder C; Mazeron R
Gynecol Oncol; 2015 Nov; 139(2):288-94. PubMed ID: 26364808
[TBL] [Abstract][Full Text] [Related]
38. [Stage IB2, IIA and IIB cervical carcinoma without lymph node extension treated with neoadjuvant chemoradiotherapy].
Monnier L; Touboul E; Daraï E; Lefranc JP; Lauratet B; Ballester M; Huguet F
Bull Cancer; 2016 Feb; 103(2):164-72. PubMed ID: 26822905
[TBL] [Abstract][Full Text] [Related]
39. Does obesity influence the preferred treatment approach for early-stage cervical cancer? A cost-effectiveness analysis.
Bohn JA; Hernandez-Zepeda ML; Hersh AR; Munro EG; Kahn JM; Caughey AB; Bruegl A
Int J Gynecol Cancer; 2022 Feb; 32(2):133-140. PubMed ID: 34887286
[TBL] [Abstract][Full Text] [Related]
40. Completion hysterectomy after radiation therapy for bulky cervical cancer stages IB, IIA, and IIB: complications and survival rates.
Decker MA; Burke JJ; Gallup DG; Silverio RW; Weems D; Duttenhaver J; Purcell D
Am J Obstet Gynecol; 2004 Aug; 191(2):654-8; discussion 658-60. PubMed ID: 15343258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
